PL442904A1 - Preparat zawierający glutation, twarda dojelitowa kapsułka zawierająca preparat glutationu oraz sposób jego wytwarzania - Google Patents
Preparat zawierający glutation, twarda dojelitowa kapsułka zawierająca preparat glutationu oraz sposób jego wytwarzaniaInfo
- Publication number
- PL442904A1 PL442904A1 PL442904A PL44290422A PL442904A1 PL 442904 A1 PL442904 A1 PL 442904A1 PL 442904 A PL442904 A PL 442904A PL 44290422 A PL44290422 A PL 44290422A PL 442904 A1 PL442904 A1 PL 442904A1
- Authority
- PL
- Poland
- Prior art keywords
- glutathione
- preparation
- production
- inulin
- lecithin
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title abstract 10
- 108010024636 Glutathione Proteins 0.000 title abstract 5
- 229960003180 glutathione Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 3
- 229920001202 Inulin Polymers 0.000 abstract 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 3
- 229940029339 inulin Drugs 0.000 abstract 3
- 229940067606 lecithin Drugs 0.000 abstract 3
- 235000010445 lecithin Nutrition 0.000 abstract 3
- 239000000787 lecithin Substances 0.000 abstract 3
- 239000002502 liposome Substances 0.000 abstract 3
- 239000000232 Lipid Bilayer Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 239000007902 hard capsule Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem zgłoszenia jest preparat zawierający glutation w postaci proszku, w którym dwuwarstwa lipidowa liposomów zawiera lecytynę, który to preparat zawiera inulinę jako stabilizator, przy czym stosunek wagowy glutationu do lecytyny mieści się w zakresie od 1:1 do 1:100, natomiast stosunek wagowy lecytyny do inuliny mieści się w zakresie od 1:0,1 do 1:5. Obecność inuliny stabilizuje preparat liposomów i zapobiega tworzeniu agregatów liposomów, szczególnie w warunkach odpowiadających warunkom kwasu żołądkowego. Wynalazek dostarcza również twardej kapsułki zawierającej preparat glutationu według zgłoszenia oraz sposobu jego wytwarzania.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL442904A PL247183B1 (pl) | 2022-11-22 | 2022-11-22 | Preparat zawierający glutation, twarda dojelitowa kapsułka zawierająca preparat glutationu oraz sposób jego wytwarzania |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL442904A PL247183B1 (pl) | 2022-11-22 | 2022-11-22 | Preparat zawierający glutation, twarda dojelitowa kapsułka zawierająca preparat glutationu oraz sposób jego wytwarzania |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL442904A1 true PL442904A1 (pl) | 2024-05-27 |
| PL247183B1 PL247183B1 (pl) | 2025-05-26 |
Family
ID=91227481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL442904A PL247183B1 (pl) | 2022-11-22 | 2022-11-22 | Preparat zawierający glutation, twarda dojelitowa kapsułka zawierająca preparat glutationu oraz sposób jego wytwarzania |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL247183B1 (pl) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120135068A1 (en) * | 2004-11-07 | 2012-05-31 | Guilford F Timothy | Liposome-encapsulated glutathione for oral administration |
| CN103976961A (zh) * | 2014-05-30 | 2014-08-13 | 李永吉 | 一种还原型谷胱甘肽脂质体的制备方法及其应用 |
| WO2020172594A1 (en) * | 2019-02-22 | 2020-08-27 | The Blue Group Llc | Inhalable therapeutic agent |
-
2022
- 2022-11-22 PL PL442904A patent/PL247183B1/pl unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120135068A1 (en) * | 2004-11-07 | 2012-05-31 | Guilford F Timothy | Liposome-encapsulated glutathione for oral administration |
| CN103976961A (zh) * | 2014-05-30 | 2014-08-13 | 李永吉 | 一种还原型谷胱甘肽脂质体的制备方法及其应用 |
| WO2020172594A1 (en) * | 2019-02-22 | 2020-08-27 | The Blue Group Llc | Inhalable therapeutic agent |
Non-Patent Citations (1)
| Title |
|---|
| AFINJUOMO F, ABDELLA S, YOUSSEF SH, SONG Y, GARG S.: "PHARMACEUTICALS (BASEL). 2021 AUG 26;14(9):855. DOI: 10.3390/PH14090855", INULIN AND ITS APPLICATION IN DRUG DELIVERY * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL247183B1 (pl) | 2025-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sotomayor-Gerding et al. | High carotenoid bioaccessibility through linseed oil nanoemulsions with enhanced physical and oxidative stability | |
| MY207980A (en) | Lipid compound and the composition thereof | |
| RU2014144501A (ru) | Депо-составы гидрофобного активного ингредиента и способы их получения | |
| MX2023005018A (es) | Liposomas que contienen un agonista de tlr4, preparacion y usos de los mismos. | |
| WO2012117385A3 (en) | Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it | |
| Han et al. | Bioaccessibility and cellular uptake of β-carotene in emulsion-based delivery systems using scallop (Patinopecten yessoensis) gonad protein isolates: Effects of carrier oil | |
| EP4122451A8 (en) | Small liposomes for delivery of immunogen-encoding rna | |
| MX2015012200A (es) | Composiciones de oxaliplatino en liposomas para la terapia contra el cancer. | |
| MY150500A (en) | Stable nutritional powder | |
| Gilmore et al. | The role of squalene in the organization of monolayers derived from lipid extracts of Halobacterium salinarum | |
| JP2019518739A5 (pl) | ||
| WO2012069836A3 (en) | Biologically active complex and its preparation | |
| NZ596848A (en) | Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) | |
| JP2017517533A5 (pl) | ||
| TW200924738A (en) | Oral formulations of bis (thiohydrazide amides) | |
| BR112022007605A2 (pt) | Composições compreendendo compostos superfinos e produção das mesmas | |
| RU2008114496A (ru) | Противомикробные препараты, содержащие инкапсулированный в липосомах октенидина дигидрохлорид | |
| US8518438B2 (en) | Highly concentrated liquid acetaminophen solutions | |
| Cui et al. | Lamellar self-assemblies of single-chain amphiphiles and sterols and their derived liposomes: Distinct compositions and distinct properties | |
| PL439126A1 (pl) | Preparat witaminy B12 oraz sposób jego wytwarzania | |
| Bui et al. | Melting-temperature-dependent interactions of ergosterol with unsaturated and saturated lipids in model membranes | |
| PL442854A1 (pl) | Preparat zawierający witaminę D3, twarda dojelitowa kapsułka żelowa zawierająca preparat witaminy D3 oraz sposób jego wytwarzania | |
| PL383287A1 (pl) | Kompozycja lipidowa do wytwarzania lipidowego nośnika dla leków genetycznych i jej zastosowanie | |
| CN103976961B (zh) | 一种还原型谷胱甘肽固体脂质纳米粒的制备方法及其应用 | |
| PL440166A1 (pl) | Preparat witaminy B kompleks, twarda dojelitowa kapsułka żelowa zawierająca preparat witaminowy oraz sposób jego wytwarzania |